Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A.
April 04 2017 - 10:18AM
Business Wire
Regulatory News:
At today’s Annual General Shareholders' Meeting (AGM) of
Sartorius Stedim Biotech S.A. in Aubagne, France, shareholders
approved the Board of Directors’ proposals by a large majority.
The AGM thus passed the resolution to pay a dividend of €0.42
net per share for fiscal 2016. The previous year’s dividend,
adjusted for the stock split that was implemented in June 2016, was
€0.33. The total profit distributed will therefore rise by 26.0%
from €30.7 million to €38.7 million.
A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading international supplier of
products and services that enable the biopharmaceutical industry to
develop and manufacture drugs safely and efficiently. As a total
solutions provider, Sartorius Stedim Biotech offers a portfolio
covering nearly all steps of biopharmaceutical manufacture. The
company focuses on single-use technologies and value-added services
to meet the rapidly changing technology requirements of the
industry it serves. Headquartered in Aubagne, France, Sartorius
Stedim Biotech is quoted on the Eurolist of Euronext Paris. With
its own manufacturing and R&D sites in Europe, North America
and Asia and an international network of sales companies, Sartorius
Stedim Biotech has a global reach. In 2016, the company employed
approx. 4,700 people, and earned sales revenue of 1,051.6 million
euros.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170404005967/en/
Sartorius Stedim BiotechPetra KirchhoffVice President of
Corporate CommunicationsPhone:
+49(0)551.308.1686petra.kirchhoff@sartorius.com
WisdomTree International... (AMEX:DIM)
Historical Stock Chart
From Oct 2024 to Nov 2024
WisdomTree International... (AMEX:DIM)
Historical Stock Chart
From Nov 2023 to Nov 2024
